Welcome to Noden Pharma

Welcome to
Noden Pharma


Noden Pharma DAC

Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines. Corporate headquarters are located in Dublin, Ireland.


In today’s environment, behaving with integrity and honesty is essential to creating a culture which promotes high ethical standards. At Noden, we strive to be a responsible corporate citizen employing a principled approach which is prevalent throughout all interactions.


Noden is committed to providing medicines, in a responsible manner, which enhance the lives of people around the world. Advancing positive health outcomes is the goal for Noden and the shared focus for all employees.


Noden offers a unique proposition as a small company with a global platform. We are also differentiated based on our view of specialty pharma. At Noden we take a discerning view on product selection and asset optimization.

Origin of Noden

Noden is derived from "Nodens" a Celtic deity associated with healing and hunting. The name Nodens is cognate with Nuada, an important figure from Irish mythology. Nuada was a great hunter and the first king of the Tuatha Dé Danann, who was disqualified from kingship after losing his hand in battle. However, his hand was restored after he was given a working silver one by the divine-smith.

He was also worshipped in ancient Britain, most notably in a temple complex at Lydney Park in Gloucestershire between 300 to 500 AD. The devoted made offerings of small bronze representations of their diseased limbs. He was sometimes identified with the protective Mars or the regenerative Silvanus and his companion and symbol was a deerhound whose lick could cure the afflicted.

Noden Pharma DAC connects with Nodens as it is a company that values highly the core principles behind the Nodens legacy; Healing: Improving health outcomes and quality of life. Hunt: Product search and acquisition is an integral part of our strategy. In fact, the Noden Pharma emblem depicts a bird in full flight and each of its multi-coloured wings are formed in the shape of the healing hands of Nodens.

Management Team

Noden Pharma DAC

Mr Markey has over 25 years’ executive experience in the International Pharmaceutical and Medical Device Sectors. He began his career in healthcare with Johnson and Johnson as a Marketing Manager. In 1997 he joined Wyeth Pharmaceuticals (acquired by Pfizer Inc) where he held a variety of commercial roles of increasing responsibility, including Sales and Marketing Director Ireland. In 2007 he was appointed Vice President EMEA for Pfizer’s Inflammation Division and was a key member of the company’s European Operating Committee. Before joining Noden, he was Managing Director of Baxter Healthcare Ireland, where he led several large transformation initiatives. As a Chartered Director, he has broad experience in both Executive and Non-Executive Director Roles. He is also a past Chairman of the Irish Surgical and Medical Trade Association. Mr Markey is a member of the Chartered Institute of Marketing, is a registered Chartered Director and holds an MBA (Finance) from Middlesex University.

Michael CONLAN, Chief Financial Officer
Noden Pharma DAC

Michael brings 12 years of accounting and financial reporting experience to the role. Before joining Noden in December 2016, Michael worked with KPMG for 7 years in both the Audit and Advisory departments. At the time of his departure, he was an Audit Manager handling a number of engagements including high profile public interest entities and companies in the life sciences sector. Michael joined Noden in December 2016 as Finance Manager and was promoted to Associate Financial Controller in August 2017. In May 2019, he was appointed Group Financial Controller and currently holds the position of Chief Financial Officer since September 2020. He is a Chartered Accountant and holds a Bachelor of Commerce International degree from University College Dublin.

Loretta CUNNINGHAM, Head of Quality
Noden Pharma DAC

Ms Cunningham is a senior pharmaceutical quality professional with 18 years of collaborative experience working within the Pharmaceutical and Biopharmaceutical companies including Chanelle Pharmaceuticals, PPD, Pfizer and Alexion.

Prior to joining Noden Pharma DAC Ms Cunningham held a number of roles with increasing responsibilities throughout her career to date. Following 9 years’ experience in a Senior QA function at the leading generic pharmaceutical company Ms Cunningham joined PPD where she was responsible the QA oversight of Phase I, II and III Clinical Trials. Ms Cunningham joined Pfizer in 2015 as Contract Operations Quality Manager responsible for CMO management of Pfizer products within the European, US and ROW markets managing ongoing metrics, regulatory variations, change control management and oversight of the quality deviations and complaints process. Ms Cunningham then joined Alexion (AstraZeneca) where she managed a Quality Team responsible for local quality operations in the Ireland division. Ms. Cunningham joined Noden Pharma DAC in 2017 and is responsible for all quality related activities performed internally, and externally, including QP disposition.

Ms. Cunningham holds a Master’s of Science in Industrial Pharmaceutical Science, a Bachelor of Science (Hons.) in Biopharmaceutical Science, a Bachelor of Science in Quality Management, as well as Diploma in Quality Management. Ms. Cunningham is also a certified IRCA Internal and External Lead Auditor.

Donal O'GRADY, Head of Technical Operations
Noden Pharma DAC

Donal is a (bio) pharmaceutical Technical Operations leader, with over 25 years’ experience in the industry. Over the last 12 years, he has held senior roles in external supply organisations, with responsibility for global external network strategy, procurement and supply operations in a number of companies, including Biomarin, Zoetis, BMS and Lonza. Prior to that he had site roles, to General manager level, leading small and large molecule end to end value streams, in Fournier Labs, Wyeth and Schering Plough. He holds a BSc in Biotechnology from DCU, a post graduate certified diploma in Accounting and Finance (ACCA) and is a certified Lean Six Sigma Black Belt.


United States

Authorized Generics

Logo Aliskiren 150MG
Logo Aliskiren 300MG
Distributor of Record: Prasco Laboratories
Prescribing Information


Logo Rasilez HCT Canada
**Rasilez HCT sales were discontinued in Canada February 2020 for commercial reasons.
Product Monograph


For Business Development or Licensing queries, please contact:

Alan Markey, CEO
Email: amarkey@nodenpharma.com

Michael Conlan, CFO
Email: mconlan@nodenpharma.com

Noden Pharma Sustainability Report 2022

At Noden Pharma we are committed to becoming a more sustainable business. Each year we intend to build on our performance and to develop as a top performer in sustainability amongst similar sized companies within our industry. Please find attached our 2022 Sustainability report.

Download PDF